Atlas Trials

REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT

Clinical trial NCT01762592 · WITHDRAWN

Trial details

NCT number
NCT01762592
Sponsor
Heidelberg Pharma AG
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Renal Cell CarcinomaKidney Cancer
Start date
2017-12-01
Primary completion
2018-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.